TegoScience Balance Sheet Health
Financial Health criteria checks 3/6
TegoScience has a total shareholder equity of ₩46.4B and total debt of ₩1.4B, which brings its debt-to-equity ratio to 2.9%. Its total assets and total liabilities are ₩48.9B and ₩2.5B respectively.
Key information
2.9%
Debt to equity ratio
₩1.35b
Debt
Interest coverage ratio | n/a |
Cash | ₩20.91b |
Equity | ₩46.41b |
Total liabilities | ₩2.50b |
Total assets | ₩48.91b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: A191420's short term assets (₩25.8B) exceed its short term liabilities (₩2.1B).
Long Term Liabilities: A191420's short term assets (₩25.8B) exceed its long term liabilities (₩404.0M).
Debt to Equity History and Analysis
Debt Level: A191420 has more cash than its total debt.
Reducing Debt: A191420's debt to equity ratio has increased from 0% to 2.9% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Insufficient data to determine if A191420 has enough cash runway based on its current free cash flow.
Forecast Cash Runway: Insufficient data to determine if A191420 has enough cash runway if its free cash flow continues to grow or shrink based on historical rates.